{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:54:14Z","timestamp":1791161654124,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1097\/gme.0b013e3181a816be","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T03:18:16Z","timestamp":1257391096000},"page":"1102-1108","source":"Crossref","is-referenced-by-count":66,"title":["Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis"],"prefix":"10.1097","volume":"16","author":[{"given":"JoAnn V.","family":"Pinkerton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulf H.","family":"Utian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Menegoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadi A.","family":"Chines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger D.","family":"Constantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210227","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","article-title":"Endometrial pathologies associated with postmenopausal tamoxifen treatment.","volume":"94","author":"Cohen","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R2-10-20210227","first-page":"660","article-title":"Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.","volume":"81","author":"Lahti","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R3-10-20210227","first-page":"18","article-title":"","volume":"2374","year":"1998","journal-title":"SCRIP"},{"key":"R4-10-20210227","first-page":"21","article-title":"","volume":"2431","year":"1999","journal-title":"SCRIP"},{"key":"R5-10-20210227","first-page":"755","article-title":"Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.","volume":"86","author":"Alexandersen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-10-20210227","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1067\/mob.2002.123938","article-title":"Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study.","volume":"187","author":"Goldstein","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R7-10-20210227","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7863\/jum.1999.18.7.503","article-title":"Sonographic assessment of the endometrium in osteopenic postmenopausal women treated with idoxifene.","volume":"18","author":"Fleischer","year":"1999","journal-title":"J Ultrasound Med"},{"key":"R8-10-20210227","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/00016340500345691","article-title":"What can be learned from the levormeloxifene experience?","volume":"85","author":"Ravn","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R9-10-20210227","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1749-6632.2001.tb04039.x","article-title":"Developing a SERM: stringent preclinical selection criteria leading to an acceptable candidate (WAY-140424) for clinical evaluation.","volume":"949","author":"Komm","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"R10-10-20210227","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/en.2005-0030","article-title":"Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity.","volume":"146","author":"Komm","year":"2005","journal-title":"Endocrinology"},{"key":"R11-10-20210227","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.AOG.0000163253.27610.b9","article-title":"Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.","volume":"105","author":"Ronkin","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R12-10-20210227","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","article-title":"Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.","volume":"23","author":"Miller","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R13-10-20210227","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo- and active-controlled clinical trial.","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R14-10-20210227","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1358\/dof.2002.027.02.637843","article-title":"Bazedoxifene acetate.","volume":"27","author":"Miller","year":"2002","journal-title":"Drugs Future"},{"key":"R15-10-20210227","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R16-10-20210227","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/jnci\/91.19.1654","article-title":"Tamoxifen therapy for breast cancer and endometrial cancer risk.","volume":"91","author":"Bernstein","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R17-10-20210227","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0002-9378(97)70091-7","article-title":"Effects of raloxifene hydrochloride on the endometrium of postmenopausal women.","volume":"177","author":"Boss","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R18-10-20210227","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"R19-10-20210227","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1067\/mob.2000.104768","article-title":"Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women.","volume":"182","author":"Fugere","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"R20-10-20210227","first-page":"95","article-title":"A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium.","volume":"95","author":"Goldstein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R21-10-20210227","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.AOG.0000137349.79204.b8","article-title":"Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.","volume":"104","author":"Grady","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R22-10-20210227","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-200916060-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:06:14Z","timestamp":1786039574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200916060-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181a816be","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}